Skip to content
Recall Observatory FDA recall evidence

Device product

SARS CoV 2 rapid antigen test kits packaged under the following brands: Oral Rapid Test, Oral Rapid Antigen Test, SML LDT Kits, SML Brand Finished Kits, SML Brand BT Test Kits, SML Brand BT Antigen Test Kit LDT

Z-1401-2022

June 15, 2022

Class I

Product summary

Firm
North American Diagnostics
Event
Event 90381
Status
Ongoing
Classification
Class I
Quantity
122,366 units
Official record key
device-enforcement:Z-1401-2022

Official wording

Reason: Various brands of SARS CoV 2 Antigen Rapid Test kits were offered for sale and distribution to consumers in the United States without marketing approval, clearance, or authorization from FDA.

Code information: Lot: FLUSA 1020-1, Batches 8, 10, and 12

Distribution pattern: Worldwide distribution - US Nationwide distribution in the states of FL, LA, NV, CA, CO, AZ, CT, OH. IL, NY, DC, MD, PA, and the countries of Zambia, Austria, Canada, UAE, Bangladesh.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Various brands of SARS CoV 2 Antigen Rapid Test kits were offered for sale and distribution to consumers in the United States without marketing approval, clearance, or authorization from FDA.